BACTROBAN NASAL OINTMENT 2% W/W [SIN05075P]

Product Info

BACTROBAN NASAL OINTMENT 2% W/W

[SIN05075P]

Indications

Elimination of nasal carriage of staphylococci, including methicillin-resistant Staphylococcus aureus (MRSA).

For the treatment of bacterial skin infections BACTROBAN ointment should be used. See package leaflet for this BACTROBAN formulation or contact the manufacturer for details. – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.

Dosage and Administration

Populations

Adults and Children: BACTROBAN nasal ointment should be applied to the anterior nostrils 2 to 3 times a day, as follows:

A small amount of ointment, about the size of a match head is squeezed on the little finger or a cotton-tipped applicator, if available.

The ointment is applied to the inside of one nostril.

This is repeated for the other nostril.

The nostrils are closed by pressing the sides of the nose together. This spreads the ointment throughout the nostrils.

Nasal carriage should normally clear within 3 to 5 days of commencing treatment.

Dosage should not exceed 10 days.

Do not mix with other preparations as there is a risk of dilution, resulting in a reduction in the antibacterial activity and potential loss of stability of the mupirocin in the ointment.

Contraindications

BACTROBAN nasal ointment should not be given to patients with a history of hypersensitivity to mupirocin or any of the constituents of the preparations.